<DOC>
	<DOCNO>NCT00982397</DOCNO>
	<brief_summary>The purpose study two-fold . In Phase I ( Protecta Clinical Study ) , system performance evaluate . In Phase II ( PainFree SST ) , inappropriate shock-free rate one year subject implant Medtronic Protecta implantable cardioverter defibrillator ( ICD ) cardiac resynchronization therapy defibrillator ( CRT-D ) evaluate . Phase II study begin Medtronic Protecta device market release participate geography . Subjects enrol Phase I study continue follow Phase II .</brief_summary>
	<brief_title>Study Evaluate System Safety Clinical Performance Protecta Implantable Cardioverter Defibrillator ( ICD ) Plus Cardiac Resynchronization Therapy Defibrillator ( CRT-D )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Patients meet one follow criterion include Phase I study : Patients indicate ( per local indication ) dual chamber implantable cardioverter defibrillator ( DRICD ) /cardiac resynchronization therapy defibrillator ( CRTD ) Patients undergoing device replacement upgrade DRICD CRTD protocol require lead ( patient must enrol prior implant ) Patients meet one follow criterion include Phase II study : Patients indicate DRICD/VRICD/CRTD device intend receive Protecta device Patients undergo DRICD/VRICD/CRTD device replacement upgrade Protecta DRICD/VRICD CRTD Patients indicate DRICD/VRICD/CRTD already implant Protecta device protocol require lead , yet discharge implant Patients mechanical tricuspid heart valve Patients enrol intend participate concurrent drug and/or device study , would confound result trial determine Medtronic , course clinical study Patients medical condition preclude test require patient study protocol otherwise limit study participation require patient Patients exclusion criterion require local law ( e.g . age , pregnancy , breast feeding , etc ) Patients anticipated able complete study Patients unwilling provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>